Your browser doesn't support javascript.
loading
PIGN gene expression aberration is associated with genomic instability and leukemic progression in acute myeloid leukemia with myelodysplastic features.
Teye, Emmanuel K; Sido, Abigail; Xin, Ping; Finnberg, Niklas K; Gokare, Prashanth; Kawasawa, Yuka I; Salzberg, Anna C; Shimko, Sara; Bayerl, Michael; Ehmann, W Christopher; Claxton, David F; Rybka, Witold B; Drabick, Joseph J; Wang, Hong-Gang; Abraham, Thomas; El-Deiry, Wafik S; Brodsky, Robert A; J Hohl, Raymond; Pu, Jeffrey J.
Affiliation
  • Teye EK; Penn State Hershey Cancer Institute and Department of Medicine, Penn State University College of Medicine, Hershey, Pennsylvania, USA.
  • Sido A; Penn State Hershey Cancer Institute and Department of Medicine, Penn State University College of Medicine, Hershey, Pennsylvania, USA.
  • Xin P; Penn State Hershey Cancer Institute and Department of Medicine, Penn State University College of Medicine, Hershey, Pennsylvania, USA.
  • Finnberg NK; Department of Hematology/Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania, USA.
  • Gokare P; Department of Hematology/Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania, USA.
  • Kawasawa YI; Institute for Personalized Medicine and Departments of Pharmacology, Biochemistry and Molecular Biology, Penn State University College of Medicine, Hershey, Pennsylvania, USA.
  • Salzberg AC; Institute for Personalized Medicine and Departments of Pharmacology, Biochemistry and Molecular Biology, Penn State University College of Medicine, Hershey, Pennsylvania, USA.
  • Shimko S; Penn State Hershey Cancer Institute and Department of Medicine, Penn State University College of Medicine, Hershey, Pennsylvania, USA.
  • Bayerl M; Department of Pathology, Penn State University College of Medicine, Hershey, Pennsylvania, USA.
  • Ehmann WC; Penn State Hershey Cancer Institute and Department of Medicine, Penn State University College of Medicine, Hershey, Pennsylvania, USA.
  • Claxton DF; Penn State Hershey Cancer Institute and Department of Medicine, Penn State University College of Medicine, Hershey, Pennsylvania, USA.
  • Rybka WB; Penn State Hershey Cancer Institute and Department of Medicine, Penn State University College of Medicine, Hershey, Pennsylvania, USA.
  • Drabick JJ; Department of Pathology, Penn State University College of Medicine, Hershey, Pennsylvania, USA.
  • Wang HG; Penn State Hershey Cancer Institute and Department of Medicine, Penn State University College of Medicine, Hershey, Pennsylvania, USA.
  • Abraham T; Department of Pediatrics, Penn State University College of Medicine, Hershey, Pennsylvania, USA.
  • El-Deiry WS; Department of Neural and Behavioral Science and the Microscopy Imaging Facility, Pennsylvania State University, Hershey, Pennsylvania, USA.
  • Brodsky RA; Department of Hematology/Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania, USA.
  • J Hohl R; Division of Hematology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • Pu JJ; Penn State Hershey Cancer Institute and Department of Medicine, Penn State University College of Medicine, Hershey, Pennsylvania, USA.
Oncotarget ; 8(18): 29887-29905, 2017 May 02.
Article in En | MEDLINE | ID: mdl-28187452

Full text: 1 Database: MEDLINE Main subject: Phosphotransferases / Myelodysplastic Syndromes / Leukemia, Myeloid, Acute / Gene Expression Regulation, Leukemic / Genomic Instability Type of study: Prognostic_studies / Risk_factors_studies Limits: Female / Humans / Male Language: En Journal: Oncotarget Year: 2017 Type: Article Affiliation country: United States

Full text: 1 Database: MEDLINE Main subject: Phosphotransferases / Myelodysplastic Syndromes / Leukemia, Myeloid, Acute / Gene Expression Regulation, Leukemic / Genomic Instability Type of study: Prognostic_studies / Risk_factors_studies Limits: Female / Humans / Male Language: En Journal: Oncotarget Year: 2017 Type: Article Affiliation country: United States